Ozempic

“Yeah, it's 1200 dollars a month. It's a hundred dollars a month in Mexico, so the American health system is causing a 90% markup.”

“Even if we have these studies, we have no long-term benefits or studies on this stuff. And, like, it just seems highly risky to me, I gotta say. Highly risky.”

“It's going to drop in the next five years. Like, that has to, both with competitive pressure, and then, you know, advances.”

“There was a new paper that came out that actually proved that there is a reduction of heart attack and stroke risk by 20% for those that have used Ozempic”

“Well, just that like Ozempic is like, is rich people face filters, right? Cause it's like, it's more expensive. It's in person. Anyone can look good on the internet, but not anyone can look good in real life. So this actually relates to our body thing too, but…”

“I think what it's worth is very bearish on Ozempic, because they're gonna run out of people. They're just gonna run out of growth.”

“They're already dropping pricing. They just dropped it in half in the last month.”